biguanides has been researched along with Benign Neoplasms, Brain in 1 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Roh, TH | 1 |
| Lee, JH | 1 |
| Kim, SJ | 1 |
| Shim, JK | 1 |
| Park, J | 1 |
| Yoon, SJ | 1 |
| Teo, WY | 1 |
| Kim, SH | 1 |
| Chang, JH | 1 |
| Kang, SG | 1 |
1 other study available for biguanides and Benign Neoplasms, Brain
| Article | Year |
|---|---|
A novel biguanide (IM1761065) inhibits bioenergetics of glioblastoma tumorspheres.
Topics: Adenosine Triphosphate; Animals; Biguanides; Brain Neoplasms; Cell Line, Tumor; Energy Metabolism; G | 2022 |